Location History:
- Vendelso, SE (2017 - 2019)
- Vendelsö, SE (2021 - 2024)
Company Filing History:
Years Active: 2017-2024
Title: Innovator Spotlight: Magnus Berglund
Introduction
Magnus Berglund, an accomplished inventor based in Vendelso, Sweden, has made notable contributions to the field of biotechnology, particularly in the area of therapeutic polypeptides. With a total of four patents to his name, Berglund's innovations are paving the way for advancements in medical treatments.
Latest Patents
Berglund's recent work has focused on "Polypeptides binding to human complement C5." This invention includes C5 binding polypeptides that possess a specific binding motif, designated as BM. The motif consists of an amino acid sequence selected from: i) EXXXA XXEID XLPNL XXXQW XAFIXXLXD, and ii) any amino acid sequence demonstrating at least 86% identity to the former. The implications of this invention lie in its potential therapeutic applications for treating conditions related to C5.
Career Highlights
Throughout his career, Magnus served with distinction at notable companies such as Swedish Orphan Biovitrum AB (publ) and IPC Research, LLC. His work within these esteemed organizations has enhanced his expertise and facilitated his inventive journey in the biotechnology sector.
Collaborations
Berglund has collaborated with several professionals in the field, including Charlotta Berghard and Patrik Strömberg. These collaborations have fostered a dynamic exchange of ideas and strategies, contributing to the successful development of his patents and innovations.
Conclusion
In summary, Magnus Berglund stands out as a significant inventor in biotechnology, particularly for his advancements related to polypeptides that interact with complement C5. His work emphasizes the importance of innovation in therapeutic solutions, reflecting his commitment to enhancing medical treatments through cutting-edge research and collaboration.